“It’s a really important day for all of America,” US Food and Drug Administration Commissioner Dr. Stephen Hahn told NBC’s Savannah Guthrie Thursday as the FDA’s Vaccines and Related Biological Products Advisory Committee meets to discuss emergency authorization of Pfizer’s Covid-19 vaccines.
“It’s an emotional one, obviously, because the country has been through so much in this pandemic,” Hahn said. “It’s affected so many lives in devastating ways.”
Thinking about how to get beyond the pandemic, Hahn said that a vaccine will be “the primary way in terms of stopping the spread beyond the mitigation efforts we need right now.”
“So if, in fact, there is an authorization and we begin vaccinating, a national vaccine campaign, there is great hope, great light for this country and I think we all look forward to getting beyond this and having a more normal and healthy life,” Hahn said.
More on today's meeting: The advisory committee is expected to vote on a recommendation to the FDA on an emergency use authorization this afternoon. The vote doesn't mean the vaccine is authorized immediately. The decision comes from the FDA, which typically follows the advisory committee's recommendation.